Earnings Feed
Start Free
Twist Bioscience Corp·4

Feb 13, 5:10 PM ET

Laponis Adam 4

Research Summary

AI-generated summary

Updated

Twist Bioscience (TWST) CFO Adam Laponis Sells 7,000 Shares

What Happened
Adam Laponis, Chief Financial Officer of Twist Bioscience (TWST), sold 7,000 shares on February 12, 2026, at $50.00 per share for total proceeds of $350,000. This was a sale (disposition) rather than a purchase or option exercise.

Key Details

  • Transaction date and price: 2026-02-12 — 7,000 shares at $50.00 each.
  • Total proceeds: $350,000.
  • Shares owned after transaction: Not specified in the information provided on this Form 4.
  • Footnote: Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025.
  • Filing timeliness: Report filed 2026-02-13 for a 2026-02-12 transaction (appears timely).

Context
Sales under 10b5-1 plans are pre-scheduled and are common for insiders to meet liquidity goals or diversify holdings; they do not necessarily indicate a change in view on the company. For retail investors, purchases typically carry more signal value than routine sales, but tracking insider activity alongside fundamentals and other news can be useful.